Bone MarrowBone Marrow CellsBone Marrow TransplantationProgram EvaluationTransplantation, HomologousKidney TransplantationBone Marrow DiseasesProgram DevelopmentBone Marrow ExaminationGraft SurvivalHematopoietic Stem CellsTissue DonorsGraft RejectionBone Marrow NeoplasmsTime FactorsLiver TransplantationMice, Inbred C57BLBone Marrow PurgingHematopoiesisGraft vs Host DiseaseGovernment ProgramsHeart TransplantationTreatment OutcomeColony-Forming Units AssayTransplantationHematopoietic Stem Cell TransplantationRadiation ChimeraCell DifferentiationWhole-Body IrradiationSpleenUnited StatesOrgan TransplantationImmunosuppressionRetrospective StudiesTransplantation ChimeraHistocompatibility TestingCells, CulturedTransplantation, AutologousLeukemiaAnemia, AplasticFlow CytometryLung TransplantationT-LymphocytesCytomegalovirus InfectionsLiving DonorsNational Health ProgramsStromal CellsMice, Inbred BALB CFollow-Up StudiesTransplantation ImmunologyCyclosporineHistocompatibilityRisk FactorsHealth PromotionTransplantation, IsogeneicAntigens, CD34GranulocytesPostoperative ComplicationsMice, KnockoutManaged Care ProgramsCell SeparationTacrolimusTransplantation ConditioningChimeraRecurrenceHealth EducationMice, TransgenicLeukemia, Myeloid, AcuteTissue and Organ ProcurementProspective StudiesAcute DiseasePilot ProjectsMice, Inbred StrainsSoftwareCell LineageTransplantsPolymerase Chain ReactionMegakaryocytesImmunization ProgramsPancytopeniaThymus GlandPancreas TransplantationStem CellsImmunophenotypingAntibodies, MonoclonalSurvival AnalysisQuestionnairesImmunocompromised HostLymphocyte DepletionMyelodysplastic SyndromesIsoantibodiesCyclophosphamideLeukocyte CountIncidenceHematologic NeoplasmsSkin TransplantationAntilymphocyte SerumGranulocyte Colony-Stimulating FactorCell DivisionMultiple Myeloma